Bengaluru, July 14 -- During Monday's trading session, shares of a research-based Global Pharmaceutical and Biotech company surged nearly 5.3 percent on BSE, after announcing a strategic realignment of its US business to focus on an innovative portfolio.

With a market capitalisation of Rs. 29,981 crores, at 12:27 p.m., the shares of Wockhardt Limited were trading in the green at Rs. 1,845.2 on BSE, up by nearly 5 percent, as against its previous closing price of Rs. 1,756.75. The stock has delivered multibagger returns of around 120 percent in one year, and has gained by over 2 percent in the last one month.

What's the News

Wockhardt Limited, in its latest regulatory filings with the stock exchanges, has announced undertaking a signifi...